Department of Analytical Chemistry, Medical University of Lublin, 20-093 Lublin, Poland.
The Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA.
Nutrients. 2020 Nov 22;12(11):3581. doi: 10.3390/nu12113581.
Selenium is involved in many metabolic pathways that are critical for life. Information concerning the metabolic effects of selenium in autism spectrum disorder (ASD) and obesity is still conflicting and incomplete. The pre- and post-pubertal selenium profiles of patients with ASD and obesity have not yet been investigated. The goal of the study was to examine selenium content before and after puberty in euthyroid children diagnosed with ASD, compared to age-matched neurotypical controls, with respect to overweight or obesity as a co-existing pathology. Serum, toenail, and 24h urine selenium levels were determined by inductively coupled plasma mass spectrometry in 287 prepubertal children (mean age 8.09 years), divided into groups: ASD with overweight/obesity (ASD+/Ob+); ASD without overweight/obesity (ASD+/Ob-); non-ASD with overweight/obesity (ASD-/Ob+); and non-ASD without overweight/obesity (ASD-/Ob-). The assessment was repeated in 258 of the children after puberty (mean age 14.26 years).The lowest serum ( < 0.001), urine ( < 0.001) and toenail ( < 0.001) selenium levels before and after puberty were observed in ASD+/Ob+ patients, and the highest in ASD-/Ob-. There were no differences in serum/toenail selenium levels between ASD+/Ob- and ASD-/Ob+ groups. The presence of ASD was associatedwith lower serum ( < 0.001) and toenail ( < 0.001) selenium in BMI-matched groups. In neurotypical patients, post-pubertal serum selenium levels were lower ( < 0.001) than pre-pubertal levels. In the multiple linear regression analyses, selenium levels showed inverse relationships with BMI ( < 0.001) and male gender ( < 0.001), irrespective of the sample type. The serum ( = 0.002) and toenail ( < 0.001) selenium levels were inversely associated with the presence of ASD. ASD, obesity/overweight, and male gender have independent impacts on selenium levels in children. Puberty may affect selenium content in neurotypical children of both genders, but not in ASD patients.
硒参与了许多对生命至关重要的代谢途径。关于自闭症谱系障碍 (ASD) 和肥胖症中硒的代谢影响的信息仍然存在冲突和不完整。目前尚未研究患有 ASD 和肥胖症的患者在青春期前和青春期后的硒谱。本研究的目的是检查青春期前被诊断为 ASD 的儿童的血清、趾甲和 24 小时尿液中的硒含量,与年龄匹配的神经典型对照组进行比较,同时考虑到超重或肥胖症作为共存病理。通过电感耦合等离子体质谱法测定 287 名青春期前儿童(平均年龄 8.09 岁)的血清、趾甲和 24 小时尿液中的硒水平,分为以下组:超重/肥胖的 ASD(ASD+/Ob+);无超重/肥胖的 ASD(ASD+/Ob-);超重/肥胖的非 ASD(ASD-/Ob+);无超重/肥胖的非 ASD(ASD-/Ob-)。其中 258 名儿童在青春期后(平均年龄 14.26 岁)进行了重复评估。青春期前和青春期后血清(<0.001)、尿液(<0.001)和趾甲(<0.001)中硒含量最低的是 ASD+/Ob+患者,最高的是 ASD-/Ob-。ASD+/Ob-和 ASD-/Ob+组之间血清/趾甲硒水平无差异。ASD 的存在与 BMI 匹配组中血清(<0.001)和趾甲(<0.001)硒水平较低有关。在神经典型患者中,青春期后血清硒水平低于青春期前(<0.001)。在多元线性回归分析中,硒水平与 BMI(<0.001)和男性性别(<0.001)呈负相关,而与样本类型无关。血清(=0.002)和趾甲(<0.001)中的硒水平与 ASD 的存在呈负相关。ASD、肥胖/超重和男性性别对儿童硒水平有独立影响。青春期可能会影响两性神经典型儿童的硒含量,但不会影响 ASD 患者。